American Century Companies’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-687,427
| Closed | -$27.3M | – | 2905 |
|
|
2026
Q1 | $27.3M | Sell |
687,427
-442,331
| -39% | -$11.3M | 0.01% | 1031 |
|
|
2025
Q4 | $28.3M | Buy |
1,129,758
+33,054
| +3% | +$837K | 0.01% | 993 |
|
|
2025
Q3 | $26.6M | Sell |
1,096,704
-34,004
| -3% | -$604K | 0.01% | 994 |
|
|
2025
Q2 | $14.9M | Buy |
1,130,708
+37,954
| +3% | +$481K | 0.01% | 1219 |
|
|
2025
Q1 | $15.7M | Buy |
1,092,754
+13,046
| +1% | +$213K | 0.01% | 1141 |
|
|
2024
Q4 | $18.1M | Sell |
1,079,708
-59,838
| -5% | -$991K | 0.01% | 1101 |
|
|
2024
Q3 | $18.2M | Buy |
1,139,546
+204,395
| +22% | +$2.5M | 0.01% | 1064 |
|
|
2024
Q2 | $8.44M | Buy |
935,151
+12,031
| +1% | +$114K | 0.01% | 1312 |
|
|
2024
Q1 | $10.4M | Buy |
923,120
+47,355
| +5% | +$448K | 0.01% | 1189 |
|
|
2023
Q4 | $6.97M | Buy |
875,765
+180,880
| +26% | +$1.21M | ﹤0.01% | 1293 |
|
|
2023
Q3 | $4.5M | Buy |
694,885
+23
| +0% | +$157 | ﹤0.01% | 1370 |
|
|
2023
Q2 | $4.3M | Buy |
694,862
+180,746
| +35% | +$858K | ﹤0.01% | 1359 |
|
|
2023
Q1 | $1.97M | Sell |
514,116
-312
| -0.1% | -$1.14K | ﹤0.01% | 1614 |
|
|
2022
Q4 | $1.59M | Sell |
514,428
-1,318
| -0.3% | -$4.88K | ﹤0.01% | 1638 |
|
|
2022
Q3 | $2.07M | Sell |
515,746
-1,831
| -0.4% | -$8.37K | ﹤0.01% | 1435 |
|
|
2022
Q2 | $2.52M | Buy |
517,577
+342
| +0.1% | +$2.19K | ﹤0.01% | 1340 |
|
|
2022
Q1 | $4.64M | Buy |
517,235
+112
| +0% | +$1.02K | ﹤0.01% | 1126 |
|
|
2021
Q4 | $5.82M | Buy |
517,123
+146,831
| +40% | +$1.98M | ﹤0.01% | 1010 |
|
|
2021
Q3 | $6.18M | Sell |
370,292
-1,212
| -0.3% | -$25.1K | ﹤0.01% | 976 |
|
|
2021
Q2 | $8.25M | Buy |
+371,504
| New | +$8.73M | 0.01% | 875 |
|
American Century Companies's CNTA Position: Q2 2026 in Review
American Century Companies sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 687,427 shares — an estimated $27.3M sold.
American Century Companies first reported a position in CNTA in Q2 2021 and held it in 20 quarters. The position peaked at $28.3M in Q4 2025. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.
- American Century Companies reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- American Century Companies sold 687,427 Centessa Pharmaceuticals shares in Q2 2026, an estimated $27.3M.
- American Century Companies first reported a position in Centessa Pharmaceuticals in Q2 2021 and held it in 20 quarters.
- American Century Companies's Centessa Pharmaceuticals position peaked at $28.3M in Q4 2025.
- 0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.